[Sudeck's disease--MRT as a new diagnostic procedure].
In this prospective study, we determined the value of MR as an imaging technique in diagnosis and therapy with the option of simultaneous assessment of bone and soft tissue. 20 patients with clinical diagnosis of reflex sympathetic dystrophy syndrome (RSDS) and positive results in radiogram and three-phase radionuclide bone scanning were examined by MR, using T1- and T2-weighted images before and after Gadolinium-DTPA i.v. Soft tissue and bone signal intensity changes can be classified in our diagnostic-therapeutic scheme and proven by histopathological changes. The differentiation between clinical stages is possible and allows an evaluation of course and therapy. The higher costs are justified by shorter examination time without using radiation.
Schimmerl
S
S
MR-Institut, Universität Wien.
Schurawitzki
H
H
Imhof
H
H
Canigiani
G
G
Kramer
J
J
Fialka
V
V
D000328:Adult; D000368:Aged; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000473:pathology; D003287:Contrast Media; D004164:Diphosphonates; D005069:Evaluation Studies as Topic; D005260:Female; D005682:Gadolinium; D019786:Gadolinium DTPA; D006801:Humans; D007866:Leg; D008279:Magnetic Resonance Imaging / Q000295:instrumentation / Q000379:methods; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D004369:Pentetic Acid; D011446:Prospective Studies; D011859:Radiography; D011877:Radionuclide Imaging; D012019:Reflex Sympathetic Dystrophy / Q000175:diagnosis*
D003287:Contrast Media; D004164:Diphosphonates; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; C033905:technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA
Morbus Sudeck--MRT als neues diagnostisches Verfahren.